Sqz Bio earnings beat by 0.34, revenue topped estimates
SQZDelisted Stock | USD 0.10 0.04 28.57% |
Slightly above 62% of Sqz Biotechnologies' investor base is looking to short. The analysis of current outlook of investing in Sqz Biotechnologies Co suggests that many traders are alarmed regarding Sqz Biotechnologies' prospects. Sqz Biotechnologies' investing sentiment can be driven by a variety of factors including economic data, Sqz Biotechnologies' earnings reports, geopolitical events, and overall market trends.
Sqz |
Sqz Bio earnings beat by 0.34, revenue topped estimates
Read at investing.com
Sqz Biotechnologies Fundamental Analysis
We analyze Sqz Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sqz Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sqz Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Sqz Biotechnologies is currently under evaluation in target price category among its peers.
Sqz Biotechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sqz Biotechnologies stock to make a market-neutral strategy. Peer analysis of Sqz Biotechnologies could also be used in its relative valuation, which is a method of valuing Sqz Biotechnologies by comparing valuation metrics with similar companies.
Peers
Sqz Biotechnologies Related Equities
ANTX | AN2 Therapeutics | 21.90 | ||||
PCSA | Processa Pharmaceuticals | 18.37 | ||||
MNPR | Monopar Therapeutics | 8.84 | ||||
IKT | Inhibikase Therapeutics | 6.96 | ||||
LIPO | Lipella Pharmaceuticals | 5.42 | ||||
QNRX | Quoin Pharmaceuticals | 1.69 | ||||
HOWL | Werewolf Therapeutics | 1.52 | ||||
PMVP | Pmv Pharmaceuticals | 1.25 | ||||
KZR | Kezar Life | 0.95 | ||||
SNTI | Senti Biosciences | 0.93 | ||||
FENC | Fennec Pharmaceuticals | 0.83 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
NUVB | Nuvation Bio | 0.35 | ||||
SABS | SAB Biotherapeutics | 1.02 | ||||
THRD | Third Harmonic | 2.67 | ||||
CADL | Candel Therapeutics | 4.85 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Sqz Stock
If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |